Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr;96(4):485-8.
doi: 10.3324/haematol.2011.042036.

Novel observations in hereditary hemochromatosis: potential implications for clinical strategies

Dorine W Swinkels, Robert E Fleming
Editorial

Novel observations in hereditary hemochromatosis: potential implications for clinical strategies

Dorine W Swinkels et al. Haematologica. 2011 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Putative iron regulatory pathways of hepatocyte hepcidin synthesis. This proposed model depicts two iron signals to hepcidin, one mediated by intracellular iron stores (Fe) and the other by ferri-transferrin (Tf-Fe2). Hepatocellular iron stores increase the expression of bone morphogenetic protein 6 (BMP6), which serves as an autocrine factor by interacting with surface BMP receptors. Hemojuvelin (HJV) is a BMP co-receptor which augments BMP binding. The consequent activation of intra-cellular SMAD proteins transduces a signal to increase hepcidin transcription. Under low iron conditions matriptase-2 (scissors) cleaves HJV from the cell surface, weakening the BMP6 signal. Extracellular Tf-Fe2 mediates a second iron signal. In this schema Tf-Fe2 displaces HFE from TfR1. HFE is then freed to interact with transferrin receptor 2 (TfR2). The HFE-TfR2 complex activates hepcidin transcription via MAPK and/or BMP/SMAD signaling. These pathways have recently been reviewed.
Figure 2.
Figure 2.
Proposed diagnostic and therapeutic algorithm for patients with suspected hemochromatosis. Orange boxes indicate the parts of the guideline for which the novel observations of the two publications in this issue might provide opportunities for improvement. * in case of heterozygosity for the C282Y mutations start searching for rare mutations in HFE in the other allele. Serum hepcidin/ferritin ratio may contribute to prioritization of order of gene investigations. If mutations are present the work-up is similar to that for HFE hemochromatosis with respect to phlebotomy, screening relatives, and periodic screening of the liver in the case of liver cirrhosis. ^ Low ferritin targets may lead to excessive iron absorption. Measurement of hepcidin could have a role in monitoring phlebotomy and to assess the ferritin target and frequency of phlebotomy. Figure adapted from van Bokhoven et al.
See this image and copyright information in PMC

Comment on

References

    1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399–408. - PubMed
    1. Swinkels DW, Janssen MC, Bergmans J, Marx JJ. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clin Chem. 2006;52(6):950–68. - PubMed
    1. Girelli D, Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica. 2011;96(4):500–6. - PMC - PubMed
    1. Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, et al. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica. 2011;96(4):507–14. - PMC - PubMed
    1. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010;142(1):24–38. - PubMed

MeSH terms